BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 31360093)

  • 1. Recent advances in the biology and treatment of B-cell acute lymphoblastic leukemia.
    Hefazi M; Litzow MR
    Blood Lymphat Cancer; 2018; 8():47-61. PubMed ID: 31360093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuing challenges and current issues in acute lymphoblastic leukemia.
    Kansagra A; Dahiya S; Litzow M
    Leuk Lymphoma; 2018 Mar; 59(3):526-541. PubMed ID: 28604239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into the pathophysiology and therapy of adult acute lymphoblastic leukemia.
    Jabbour E; O'Brien S; Konopleva M; Kantarjian H
    Cancer; 2015 Aug; 121(15):2517-28. PubMed ID: 25891003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances in the Biology and Treatment of T Cell Acute Lymphoblastic Leukemia.
    Hefazi M; Litzow MR
    Curr Hematol Malig Rep; 2018 Aug; 13(4):265-274. PubMed ID: 29948644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Advances in Adult Acute Lymphoblastic Leukemia.
    Richard-Carpentier G; Kantarjian H; Jabbour E
    Curr Hematol Malig Rep; 2019 Apr; 14(2):106-118. PubMed ID: 30879177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress and Innovations in the Management of Adult Acute Lymphoblastic Leukemia.
    Jabbour E; Pui CH; Kantarjian H
    JAMA Oncol; 2018 Oct; 4(10):1413-1420. PubMed ID: 29931220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dasatinib-induced complete molecular response after allogeneic hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to prior imatinib-containing regimen: a case report and discussion.
    Czyz A; Lewandowski K; Kroll R; Komarnicki M
    Med Oncol; 2010 Dec; 27(4):1123-6. PubMed ID: 19885746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical updates in adult acute lymphoblastic leukemia.
    Al Ustwani O; Gupta N; Bakhribah H; Griffiths E; Wang E; Wetzler M
    Crit Rev Oncol Hematol; 2016 Mar; 99():189-99. PubMed ID: 26777876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Approaches to the Management of Adult Acute Lymphoblastic Leukemia.
    Bassan R; Bourquin JP; DeAngelo DJ; Chiaretti S
    J Clin Oncol; 2018 Sep; ():JCO2017773648. PubMed ID: 30240326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Advances in Managing Acute Lymphoblastic Leukemia.
    DeAngelo DJ; Jabbour E; Advani A
    Am Soc Clin Oncol Educ Book; 2020 May; 40():330-342. PubMed ID: 32421447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Approaches to Philadelphia Chromosome-Positive B-Cell Lineage Acute Lymphoblastic Leukemia: Role of Tyrosine Kinase Inhibitor and Stem Cell Transplant.
    Kim K; Jabbour E; Short NJ; Kebriaei P; Kantarjian H; Ravandi F
    Curr Oncol Rep; 2021 Jun; 23(8):95. PubMed ID: 34125415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic Hematopoietic Stem Cell Transplantation, Especially Haploidentical, May Improve Long-Term Survival for High-Risk Pediatric Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Tyrosine Kinase Inhibitor Era.
    Xue YJ; Cheng YF; Lu AD; Wang Y; Zuo YX; Yan CH; Wu J; Sun YQ; Suo P; Chen YH; Chen H; Jia YP; Liu KY; Han W; Xu LP; Zhang LP; Huang XJ
    Biol Blood Marrow Transplant; 2019 Aug; 25(8):1611-1620. PubMed ID: 30537550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing Landscape in the Treatment of Adult Acute Lymphoblastic Leukemia (ALL).
    Künz T; Hauswirth AW; Hetzenauer G; Rudzki J; Nachbaur D; Steiner N
    Cancers (Basel); 2022 Sep; 14(17):. PubMed ID: 36077822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Young Adults with Acute Lymphoblastic Leukemia.
    Kansagra A; Litzow M
    Curr Hematol Malig Rep; 2017 Jun; 12(3):187-196. PubMed ID: 28353017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New approaches to the treatment of older adults with acute lymphoblastic leukemia.
    Schwartz M; Wieduwilt MJ
    Semin Hematol; 2020 Jul; 57(3):122-129. PubMed ID: 33256901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innovative Approaches to the Management of Acute Lymphoblastic Leukemia Across the Age Spectrum.
    Curran E; Muffly L; Luskin MR
    Am Soc Clin Oncol Educ Book; 2022 Apr; 42():1-11. PubMed ID: 35503981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controversies in the Treatment of Adolescents and Young Adults with Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia.
    Grover P; Muffly L
    Curr Oncol Rep; 2022 Aug; 24(8):995-1001. PubMed ID: 35353349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Acute Lymphoblastic Leukemia in Adults: Applying Lessons Learned in Children.
    Aldoss IT; Marcucci G; Pullarkat V
    Oncology (Williston Park); 2016 Dec; 30(12):1080-91. PubMed ID: 27987201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia in Adolescents and Young Adults.
    Wang AY; Muffly LS; Stock W
    JCO Oncol Pract; 2020 May; 16(5):231-238. PubMed ID: 32048928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia.
    Ram R; Storb R; Sandmaier BM; Maloney DG; Woolfrey A; Flowers ME; Maris MB; Laport GG; Chauncey TR; Lange T; Langston AA; Storer B; Georges GE
    Haematologica; 2011 Aug; 96(8):1113-20. PubMed ID: 21508120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.